MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$66,419K
(-34.99%↓ Y/Y)
Unrealized gain on
marketable securities
$70K
(-59.54%↓ Y/Y)
Net loss
-$66,489K
(-34.66%↓ Y/Y)
Interest income
$6,350K
(-12.41%↓ Y/Y)
Loss from operations
-$72,839K
(-28.63%↓ Y/Y)
Total operating
expenses
$72,839K
(26.73%↑ Y/Y)
Research and development
$55,969K
(32.18%↑ Y/Y)
General and
administrative
$16,870K
(11.48%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)